- The Development Path of China’s Private Health Insurance and Its Role in the Health Care System
-
Jung KT, Fan JC, Chen WY
- KMID: 2525766
- Health Policy Manag.
- 2021 Dec;31(4):423-436.
- doi: 10.4332/KJHPA.2021.31.4.423
This article summarizes the structure of China’s current social health insurance system and reviews the development status of China’s private health insurance (PHI). China’s medical security system is mainly composed... -
- CITED
-
- Close
- SHARE
-
- Close
- Bioactive metabolites: A clue to the link between MASLD and CKD?
-
Chen WY, Zhang JH, Chen LL, Byrne CD, Targher G, Luo L, Ni Y, Zheng MH, Sun DQ
- KMID: 2563407
- Clin Mol Hepatol.
- 2025 Jan;31(1):56-73.
- doi: 10.3350/cmh.2024.0782
Metabolites produced as intermediaries or end-products of microbial metabolism provide crucial signals for health and diseases, such as metabolic dysfunction-associated steatotic liver disease (MASLD). These metabolites include products of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy
-
Hsu YH, Li HH, Sung JM, Chen WY, Hou YC, Weng YH, Lai WT, Wu CH, Chang MS
- KMID: 2375797
- Exp Mol Med.
- 2017 Mar;49(3):e310.
- doi: 10.1038/emm.2016.169
Interleukin (IL)-20, a proinflammatory cytokine of the IL-10 family, is involved in acute and chronic renal failure. The aim of this study was to elucidate the role of IL-20 during... -
- CITED
-
- Close
- SHARE
-
- Close
